Machine Learning Quietly Advances in Cancer Prediction and Synthetic Biology

Away from the model race, researchers are publishing applied ML work on predicting cancer treatment response and generating synthetic transcriptomic data.

The specialized science side of AI rarely trends, but it's where some of the most consequential work happens. Researchers shared a study on "prediction of pathological complete response after chemoradiation for locally advanced rectal cancer using machine learning," per @JARC_JSCP. Predicting which patients will fully respond to chemoradiation is clinically significant — it could inform whether some patients avoid surgery entirely, and it's the kind of narrow, high-stakes prediction task where ML earns its keep.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae.

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede. Mauris et orci. Aenean nec lorem. In porttitor. Donec laoreet nonummy augue. Suspendisse dui purus, scelerisque at, vulputate vitae, pretium mattis, nunc. Mauris eget neque at sem venenatis eleifend. Ut nonummy. Fusce aliquet pede non pede. Suspendisse dapibus lorem pellentesque magna integer malesuada.

Unlock the full briefing

Get every story in today's briefing, the full archive, and the daily AI intelligence brief.

All stories today

Full archive

Daily brief